Roper Technologies, Inc. — FY2016 Form 10-K
Reporting period: Fiscal year ended December 31, 2016. The filing is an annual report, not a standalone fourth-quarter filing; fourth-quarter figures are also summarized below. Roper is a diversified technology company with software, SaaS and engineered-products businesses across four segments.
Financial performance and key metrics
- FY2016 revenue: $3.790 billion, up 5.8% from $3.582 billion. Acquisitions contributed 6.8%; organic growth was negative 0.3% and foreign exchange reduced growth by 0.7%.
- Profitability: Gross profit was $2.332 billion and gross margin 61.5%, up from 60.4%. Operating income rose 2.6% to $1.055 billion, while operating margin declined to 27.8% from 28.7%. Net earnings fell to $658.6 million from $696.1 million; diluted EPS was $6.43 versus $6.85. Net margin was 17.4% versus 19.4%.
- Cash flow: Operating cash flow was $963.8 million, up from $928.8 million. Investing cash outflow was $3.753 billion, primarily for acquisitions; capital expenditures were $37.3 million. Financing provided $2.805 billion, including $1.2 billion of senior notes and revolving borrowings.
- Liquidity and debt: Cash and cash equivalents were $757.2 million, including $557 million held at foreign subsidiaries. Total debt was $6.210 billion, compared with $3.271 billion a year earlier; debt was 51.8% of total capital. Revolver borrowings were $1.93 billion, with $535 million of undrawn availability reported. The company was in compliance with debt covenants at year-end.
- Other metrics: Deferred revenue increased to $488.4 million from $267.0 million. Goodwill was $8.647 billion, or 60% of total assets; no goodwill impairment was recorded in 2016. R&D spending was $195.4 million. The declared annual dividend was $1.25 per share, up from $1.05.
Segment performance
| Segment | FY2016 sales | Change vs. 2015 | Operating margin | Key reported drivers |
|---|---|---|---|---|
| Medical & Scientific Imaging | $1.363 billion | +12% | 35.0% (36.4%) | Acquisitions and organic growth, especially medical businesses; margin pressure from mix and higher SG&A. |
| RF Technology | $1.210 billion | +17% | 30.8% (30.2%) | Acquisitions and software growth; higher gross margin partly offset by higher SG&A. |
| Industrial Technology | $706.6 million | -5.2% | 28.7% (28.8%) | Oil-and-gas weakness and Abel Pumps divestiture; water metering partly offset declines. |
| Energy Systems & Controls | $510.2 million | -13% | 25.4% (27.6%) | Lower oil-and-gas sales and negative operating leverage. |
Prior-year segment margins are in parentheses. Total backlog expected to convert to revenue within 12 months rose 46.9% to $1.572 billion, with acquisitions contributing 37% and internal growth 10%. Net orders increased 9.8%.
Fourth-quarter results
Fourth-quarter 2016 sales were $1.011 billion versus $943.6 million in Q4 2015; operating income was $289.1 million versus $278.7 million. Net earnings were $182.1 million versus $208.6 million, and diluted EPS was $1.78 versus $2.05. The filing attributes the prior-year comparison in part to the 2015 Abel Pumps divestiture gain; it does not provide a separate Q4 adjusted-earnings measure.
Material changes, outlook and risks
- Acquisitions and financing: Roper completed six acquisitions, including Deltek for approximately $2.8 billion, financed in part with $1.2 billion of notes and revolver borrowing. Deltek contributed $7.9 million in revenue and $0.8 million in earnings in the few days included in 2016 results. Acquisition activity drove substantial increases in debt, goodwill and intangible assets.
- Prior-year unusual item: 2015 included a $70.9 million pretax gain on the Abel Pumps sale, contributing to higher 2015 net earnings and other income. The gain also generated $46 million of tax expense. 2016 included a $0.9 million non-cash debt-extinguishment charge.
- Management outlook: Management expected a 2017 effective tax rate of approximately 30% and capital expenditures of 1.0%–1.5% of annual sales. It expected operating cash flows to support scheduled debt reduction, while noting that acquisition needs and business performance could affect the pace. No specific revenue or EPS guidance is provided in the supplied filing text.
- Debt and liquidity risks: Debt service and covenant requirements may constrain acquisitions, dividends and other uses of cash. The leverage covenant was temporarily raised in connection with Deltek—to 4.25x through June 30, 2017 and 4.00x through December 31, 2017. About $401 million of debt maturities were scheduled for 2017.
- Business and financial risks: Energy and industrial markets are cyclical; foreign exchange, supplier constraints, competition, customer concentration in some businesses, acquisition integration, SaaS execution, cybersecurity, product liability, environmental exposure and potential impairment of goodwill or intangibles could affect results. A 10% currency-rate change, if sustained through 2016, was estimated to affect net earnings by approximately 2%.
- Contingencies and controls: Management said no accrual was necessary for contingencies and no matters had a reasonable possibility of material loss; asbestos-related claim exposure could not be determined. The company had $521 million of surety bonds and $74 million of letters of credit. Management and the auditor reported effective internal control over financial reporting, but the company disclosed a late Form 8-K filing for the Deltek closing and stated it had taken remediation steps.
Investor verification priorities
- Assess whether organic growth and order/backlog increases can translate into revenue and earnings, particularly given weakness in Energy Systems & Controls and Industrial Technology.
- Review post-Deltek leverage, covenant headroom, refinancing needs and management’s ability to reduce debt while continuing acquisitions and paying dividends.
- Check acquisition integration and the assumptions supporting the substantial goodwill and intangible balances; confirm subsequent impairment testing and amortization effects.
- Reconcile year-over-year earnings and EPS, separating the 2015 Abel sale gain and tax effects from underlying operating performance.
- Monitor foreign-currency exposure, SaaS revenue and margin execution, cybersecurity and supplier risks, and developments in asbestos, environmental and other legal matters.